Nano hemostat solution: immediate hemostasis at the nanoscale

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Regenerative Medicine

Background:

• Hemostasis presents significant challenges in surgery and trauma care, with limited effective methods to control bleeding without causing further tissue damage.
• Current hemostatic techniques often rely on pressure, cauterization, or coagulation, which can be invasive or insufficient in severe cases.

Purpose of the Study:

• To evaluate a novel self-assembling peptide-based nanotechnology for achieving rapid and effective hemostasis.
• To demonstrate the safety and efficacy of this new hemostatic agent across various mammalian tissues.

Main Methods:

• A self-assembling peptide solution was applied directly to wounds in critical organs and tissues (brain, spinal cord, femoral artery, liver, skin) in mammals.
• Hemostasis was assessed by direct observation of bleeding cessation and time to complete cessation.

Main Results:

• Complete hemostasis was achieved in all tested mammalian tissues within 15 seconds of application.
• The peptide solution formed a nanofiber barrier, stopping bleeding without external pressure, cauterization, vasoconstriction, coagulation, or adhesives.
• The solution was found to be nontoxic and nonimmunogenic, with breakdown products being natural amino acids.

Conclusions:

• This self-assembling peptide nanotechnology represents a breakthrough in hemostasis, offering immediate and complete bleeding control.
• The nontoxic and biocompatible nature of the peptide solution, coupled with its rapid efficacy, positions it as a transformative therapy for surgical and trauma-related bleeding.
• This nanotechnology has the potential to significantly reduce the need for blood transfusions in future surgical procedures.